Literature DB >> 1739845

High potency factor VIII concentrates.

E E Mayne.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1739845      PMCID： PMC1881080          DOI： 10.1136/bmj.304.6822.319-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Transient factor VIII inhibitor and treatment with monoclonal-antibody-purified factor VIII.

Authors:  J B Montoro; S Rodríguez; C Altisent; J M Tusell
Journal:  Lancet       Date:  1991-05-18       Impact factor: 79.321

2.  High potency factor VIII concentrates: value not proved?

Authors:  J D Cash
Journal:  BMJ       Date:  1991-09-14

3.  Factor VIII:C inhibitor associated with monoclonal-antibody purified FVIII concentrate.

Authors:  C M Kessler; K Sachse
Journal:  Lancet       Date:  1990-06-09       Impact factor: 79.321

4.  Inhibitors to monoclonal antibody purified factor VIII.

Authors:  B A Bell; E M Kurczynski; G Bergman
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

5.  Consistently normal CD4+, CD8+ levels in haemophilic boys only treated with a virally safe factor VIII concentrate (BPL 8Y)

Authors:  J A Evans; K J Pasi; M D Williams; F G Hill
Journal:  Br J Haematol       Date:  1991-11       Impact factor: 6.998

6.  A highly purified factor VIII:c concentrate prepared from cryoprecipitate by ion-exchange chromatography.

Authors:  T Burnouf; M Burnouf-Radosevich; J J Huart; M Goudemand
Journal:  Vox Sang       Date:  1991       Impact factor: 2.144
  6 in total
  1 in total

1.  High purity factor VIII concentrates and HIV infection.

Authors:  C A Lee
Journal:  BMJ       Date:  1992-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.